These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1618360)

  • 21. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
    Tomson T; Perucca E; Battino D
    Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EFFECTS OF MATERNAL EPILEPSY AND ANTIEPILEPTIC THERAPY IN WOMEN DURING PREGNANCY.
    Vanya M; Arva-Nagy N; Szili K; Szok D; Bártfai G
    Ideggyogy Sz; 2015 Mar; 68(3-4):105-12. PubMed ID: 26434198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age.
    Lindhout D; Omtzigt JG
    Epilepsia; 1994; 35 Suppl 4():S19-28. PubMed ID: 8174516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India.
    Thomas SV; Jose M; Divakaran S; Sankara Sarma P
    Epilepsia; 2017 Feb; 58(2):274-281. PubMed ID: 28084641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second-generation antiepileptic drugs and pregnancy: a guide for clinicians.
    Reimers A; Brodtkorb E
    Expert Rev Neurother; 2012 Jun; 12(6):707-17. PubMed ID: 22650173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model.
    Wen X; Hartzema A; Delaney JA; Brumback B; Liu X; Egerman R; Roth J; Segal R; Meador KJ
    BMC Pregnancy Childbirth; 2017 Jan; 17(1):10. PubMed ID: 28061833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal assessment of behavioural transitions in healthy human fetuses during the third trimester of pregnancy.
    Arduini D; Rizzo G; Massacesi M; Romanini C; Mancuso S
    J Perinat Med; 1991; 19(1-2):67-72. PubMed ID: 1870059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of prenatal antiepileptic drug exposure on newborn brain activity.
    Videman M; Tokariev A; Stjerna S; Roivainen R; Gaily E; Vanhatalo S
    Epilepsia; 2016 Feb; 57(2):252-62. PubMed ID: 26705760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.
    Veroniki AA; Cogo E; Rios P; Straus SE; Finkelstein Y; Kealey R; Reynen E; Soobiah C; Thavorn K; Hutton B; Hemmelgarn BR; Yazdi F; D'Souza J; MacDonald H; Tricco AC
    BMC Med; 2017 May; 15(1):95. PubMed ID: 28472982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.
    Omtzigt JG; Los FJ; Grobbee DE; Pijpers L; Jahoda MG; Brandenburg H; Stewart PA; Gaillard HL; Sachs ES; Wladimiroff JW
    Neurology; 1992 Apr; 42(4 Suppl 5):119-25. PubMed ID: 1574165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epilepsy and pregnancy.
    Oguni M; Osawa M
    Epilepsia; 2004; 45 Suppl 8():37-41. PubMed ID: 15610193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for spared attention to faces in 7-month-old infants after prenatal exposure to antiepileptic drugs.
    Videman M; Stjerna S; Roivainen R; Nybo T; Vanhatalo S; Gaily E; Leppänen JM
    Epilepsy Behav; 2016 Nov; 64(Pt A):62-68. PubMed ID: 27732918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exposure to antiepileptic drugs in pregnancy: The need for a family factor framework.
    Huber-Mollema Y; van Iterson L; Sander JW; Oort FJ; Lindhout D; Rodenburg R
    Epilepsy Behav; 2018 Sep; 86():187-192. PubMed ID: 30030084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents.
    Koch S; Titze K; Zimmermann RB; Schröder M; Lehmkuhl U; Rauh H
    Epilepsia; 1999 Sep; 40(9):1237-43. PubMed ID: 10487186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computer-assisted analysis of fetal behavioural states.
    Rizzo G; Arduini D; Mancuso S; Romanini C
    Prenat Diagn; 1988 Sep; 8(7):479-84. PubMed ID: 3222215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Birth outcomes after prenatal exposure to antiepileptic drugs--a population-based study.
    Kilic D; Pedersen H; Kjaersgaard MI; Parner ET; Vestergaard M; Sørensen MJ; Olsen J; Bech BH; Christensen J; Pedersen LH
    Epilepsia; 2014 Nov; 55(11):1714-21. PubMed ID: 25231599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Women with epilepsy in reproductive age group: special issues and management strategies.
    Begum S; Thomas SV
    J Assoc Physicians India; 2013 Aug; 61(8 Suppl):48-51. PubMed ID: 24818330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current treatment strategies in selected situations in epilepsy.
    Treiman DM
    Epilepsia; 1993; 34 Suppl 5():S17-23. PubMed ID: 8339712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
    Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S
    Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth and motor development in fetuses of women with type-1 diabetes. III. First trimester quantity of fetal movement patterns.
    Mulder EJ; Visser GH; Morssink LP; de Vries JI
    Early Hum Dev; 1991 May; 25(2):117-33. PubMed ID: 1860430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.